Biotech Valuation Message Board

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : Biotech Valuation

CRSP 55.11

-2.6%

Nov 7 3:59 PM EST

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next

To: BMcV who wrote (14966)	12/27/2004 12:27:25 PM
From: Biomaven	of 52153

People have looked at the aspirin effect in some of the studies. It adds another variable, so it makes things that much more confusing. There's an additional variable - ultra low dose aspirin vs. regular dose as well. One thing that does emerge is that specifically ibuprofen plus aspirin is NOT a good idea, for reasons that are unclear. Peter

Report TOU Violation

Share This Post

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next